The Physiological Impact of CTO PCI on Coronary Pressure Measurements and Correlation in Donor Vessel

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

42 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-10-01

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be recording pressure wire readings from both blocked and narrowed arteries, to better guide treatment options; medications, stents or potentially bypass surgery, for patients with Chronic Total Occlusion (CTO).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Impact of Coronary Chronic Total Occlusion Percutaneous Coronary Intervention on Culprit Vessel Physiology

NCT03830853

Chronic Total Occlusion of Coronary Artery

COMPLETED

Observational Study of Angiographic Coregistered Optical Coherence Tomography in Patients Undergoing PCI

NCT02919943

Coronary Artery Disease

COMPLETED

Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

NCT02026466

Coronary Artery Disease

COMPLETED

Investigating the Utility of Remote Index of Microvascular Resistance in Patients With Chronic Total Occlusion

NCT04226326

Chronic Total Occlusion

COMPLETED NA

Contemporary Clinical Treatment and Long-term Outcomes in Patient With Coronary Chronic Total Occlusion

NCT03614559

Percutaneous Coronary Intervention

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The patients in this study are planned to have a Percutaneous Coronary Intervention (PCI) with recanalization of Chronic Total Occlusion (CTO) on clinical grounds alone.

This study will be recording pressure wire readings from both blocked and narrowed arteries, to better guide treatment option. To date there is no data available on instantaneous wave free ratio (iFR) measurement (a pressure derived assessment of flow limitation) in patients with blocked arteries.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age \>18 years of age
2. Stable angina / ischaemic symptoms
3. Evidence of viability and / or ischaemia in the chronic total occlusion (CTO) territory
4. Participant is willing and able to give informed consent for participation in the study
5. Presence of a chronic total occlusion (CTO) in RCA:

* Duration of the occlusion \> 3 months;
* Thrombolysis In Myocardial Infarction (TIMI) (50) coronary flow grade 0;
* Spontaneously visible collaterals, Rentrop classification grade 1 or 2 or 3 from contralateral donor artery
6. Presence of minor to intermediate coronary stenosis (1-70 %) in the contralateral donor artery
7. Eligible for PCI to a chronic total occlusion (CTO)

Exclusion Criteria

1. Previous CABG with patent grafts to the interrogated donor artery
2. Left main stenosis of \> 40 %
3. Presence of severe flow limiting stenosis in the contralateral donor artery (typically \> 70 % stenosis)
4. Haemodynamic instability at the time of intervention (heart rate \<40 beats per minute, systolic blood pressure \<90mmHg), balloon pump)
5. Significant contraindication to adenosine administration (e.g. heart block, severe asthma)
6. Contraindications to PCI
7. Severe hepatic or lung disease (chronic pulmonary obstructive disease)
8. Pregnancy
9. ACS within 48 hours of procedure
10. Severe valvular heart disease
11. Severe cardiomyopathy / Infiltrative heart disease
12. eGFR \< 40

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No